✦ LIBER ✦

PROGRESSION AND LONG-TERM SURVIVAL AFTER SIMPLE ENUCLEATION FOR THE ELECTIVE TREATMENT OF RENAL CELL CARCINOMA: EXPERIENCE IN 107 PATIENTS

✍ Scribed by LAPINI, A; SERNI, S; MINERVINI, A; MASIERI, L; CARINI, M

Book ID: 120567823
Publisher: Lippincott Williams and Wilkins
Year: 2005
Tongue: English
Weight: 73 KB
Volume: 174
Category: Article
ISSN: 0022-5347
DOI: 10.1097/01.ju.0000162019.45820.53

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Progression and Long-term Survival After

Progression and Long-term Survival After Simple Enucleation for the Elective Treatment of Renal Cell Carcinoma: Experience in 107 Patients

✍ Ornstein, D.K. 📂 Article 📅 2006 🏛 Elsevier Science ⚖ 59 KB

PROGRESSION AND LONG-TERM SURVIVAL AFTER

PROGRESSION AND LONG-TERM SURVIVAL AFTER SIMPLE ENUCLEATION FOR THE ELECTIVE TREATMENT OF PT1A RENAL CELL CARCINOMA (RCC): OUR EXPERIENCE OVER 25 YEARS

✍ A. Lapini; A. Minervini; S. Serni; L. Masieri; F. Nelli; G. Giubilei; N. Tosi; M 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 59 KB

SIMPLE ENUCLEATION FOR THE TREATMENT OF

SIMPLE ENUCLEATION FOR THE TREATMENT OF RENAL CELL CARCINOMA BETWEEN 4 AND 7 CM IN GREATEST DIMENSION: PROGRESSION AND LONG-TERM SURVIVAL

✍ A. Minervini; S. Serni; A. Lapini; L. Masieri; M. Carloni; L. Manoni; F. Lanzi; 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 59 KB

Simple Enucleation for the Treatment of

Simple Enucleation for the Treatment of Renal Cell Carcinoma Between 4 and 7 cm in Greatest Dimension: Progression and Long-Term Survival

✍ Carini, Marco; Minervini, Andrea; Lapini, Alberto; Masieri, Lorenzo; Serni, Serg 📂 Article 📅 2006 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 113 KB

Long-Term Survival after Gemcitabine and

Long-Term Survival after Gemcitabine and Cisplatin in Patients with Locally Advanced Transitional Cell Carcinoma of the Bladder: Focus on Supplementary Treatment Strategies

✍ Anne Birgitte Als; Lisa Sengelov; Hans von der Maase 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 305 KB

Overall survival and good tolerability o

Overall survival and good tolerability of long-term use of sorafenib after cytokine treatment: final results of a phase II trial of sorafenib in Japanese patients with metastatic renal cell carcinoma

✍ Seiji Naito; Taiji Tsukamoto; Masaru Murai; Koichi Fukino; Hideyuki Akaza 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 411 KB